Chapter 4 - THE SHADOW IN THE BOARDROOM
By 9:45 AM, Wall Street was buzzing. News of the night's ballroom confrontation had swept through financial news networks, and television trucks were parked three deep outside the New York Stock Exchange building.
Inside the private 14th-floor executive conference room, the atmosphere was suffocating.
The eleven members of the Blackwell Therapeutics Board of Directors sat around a fifty-foot mahogany table. Among them were industry titans, former senators, and billionaire venture capitalists. At the head of the table sat Grant, dressed in a sharp navy suit, though the dark circles under his eyes and his disheveled hair betrayed his panic. Beside him sat Madison, frantically typing on two phones at once, her face pale.
Vivian Hawthorne sat in the visitor’s gallery in the back, clutching a designer handbag, her eyes darting nervously around the room.
"This meeting is an illegal ambush!" Madison declared loudly, standing up and slamming her hands on the table. "Eleanor Blackwell has no corporate authority to call a special session of this board! She is a private shareholder with disputed equity status!"
"Sit down, Madison," said Thomas Sterling, an eighty-year-old retired general and the longest-serving independent board member. He looked at Grant with pure disgust. "Grant, is it true? Did the feds serve you with a fraud subpoena last night?"
Grant cleared his throat, trying to regain his composure. "Tom, it's a routine inquiry based on baseless accusations from a woman who is currently going through a severe emotional breakdown. My legal team is handling it. Today's meeting should focus on finalizing the merger between Blackwell Therapeutics and Valence Bio—"
The heavy oak doors of the boardroom swung open.
I walked in, flanked by Julian Reyes and two forensic accountants from Deloitte. I was wearing a tailored black double-breasted suit, my hair pulled back in a slick, commanding bun. I carried no purse, no notes—only a black leather folder.
The board members immediately stood up out of respect—not just for me, but for the memory of my father, whose framed portrait hung directly behind Grant’s chair.
"Good morning, gentlemen," I said, taking my seat at the opposite end of the long table.
Grant glared across the distance. "Eleanor, you are not authorized to be in this room. Security—"
"Security works for the parent company, Grant," Julian interrupted, placing a stack of blue Swiss legal filings in front of every board member. "As of 8:00 AM Swiss Eastern Time, Eleanor Blackwell has formally asserted sole trustee authority over Blackwell Holdings AG. Under Section 4 of the parent charter, the parent company holds full power to reconstitute the board of any regional subsidiary at will."
Thomas Sterling quickly opened his folder, scanning the pages. A slow smile spread across the old general's face. "Well, I’ll be damned. Henry really did set up a ironclad vault."
Madison’s face turned crimson. "This is a technicality! Valence Bio holds the exclusive distribution rights to the Phase III oncology drug, Blackwell-9! Even if you control the parent board, Eleanor, without Valence Bio, Blackwell Therapeutics has no viable pipeline for the next five years! You'll bankrupt the company by afternoon!"
She leaned forward, her eyes flashing with triumphant venom. "Grant and I foresaw this. We legally transferred the patent rights for Blackwell-9 to Valence Bio three months ago. You own the shell, Eleanor. We own the cure."
A heavy silence fell over the room. Several board members looked at each other nervously. Blackwell-9 was the crown jewel of my father's research—a breakthrough drug capable of targeting aggressive tumors without destroying healthy tissue. It was worth billions, but more importantly, it was meant to save millions of lives.
Grant leaned back in his chair, a smug smirk returning to his face. "She's right, Eleanor. You might have the corporate name, but I have the science. You give me full executive control, or I walk out that door, take Blackwell-9 to Valence Bio, and leave Blackwell Therapeutics to rot."
I looked at Grant, then at Madison. I didn't panic. In fact, I couldn't help but smile.
"You really didn't read my father's research notes, did you, Grant?" I asked softly.
Grant frowned. "What are you talking about?"
I signaled to one of my forensic accountants, who opened a laptop and projected a set of technical schematics onto the main digital screen behind Grant.
"The drug you call Blackwell-9 was developed using an off-shore synthesis formula that you stole from my father's private server," I explained, pointing to the glowing chemical structures on the wall. "What you don't know is that my father purposefully archived an incomplete molecular sequence in the corporate database to identify corporate spies."
Madison gasped, her eyes darting to the screen. "That's impossible! The clinical trials in Zurich showed a ninety-two percent efficacy rate!"
"Because my father personally synthesized the missing enzyme compound in his private laboratory in Vermont," I revealed, leaning forward. "The patent you transferred to Valence Bio isn't for a miracle cure, Madison. Without the stabilization enzyme—which is patented under my personal name—the compound degrades into toxic waste within forty-eight hours of exposure to room temperature."
The boardroom erupted into chaos.
"You transferred an invalid, toxic patent to an independent firm?" General Sterling roared, slamming his fist on the table, turning his fury toward Grant. "You risked the entire financial stability of this firm on a stolen, incomplete trial?!"
"No! She's lying!" Grant shouted, jumping out of his chair. "She's manipulating the data!"
"I don't lie, Grant. I do research," I said coldly. "And right now, Valence Bio is facing three hundred million dollars in debt obligations to Swiss biotech investors for a drug you cannot produce. And guess who owns those debt obligations?"
May you like
I pulled a single sheet of paper from my black folder.
"I bought Valence Bio's debt through a private holding company an hour ago," I said, looking at Madison. "You are completely bankrupt, Madison. And as of this second, you are fired."
